Wednesday, February 10, 2016

BioClinica to be bought by private-equity firm JLL for $123 million

The Bucks County-based provider of clinical trial management services will be acquired by a New York investment firm in a cash offer of $7.25 per share.

BioClinica to be bought by private-equity firm JLL for $123 million

0 comments

BioClinica Inc., a Bucks County-based provider of clinical trial management services, will be acquired by JLL Partners Inc., a New York private-equity firm, for about $123 million.

A holding company controlled by JLL will acquire BioClinica, of Newtown, through a cash tender offer at $7.25 per share.

Shares of the publicly traded BioClinica were up 19 percent, of $1.17, at $7.22 in morning trading.

In addition, JLL will acquire Princeton-based CoreLab Partners Inc., a provider of services to the biopharmaceutical industry, and combine it with BioClinica.

BioClinica president and CEO Mark L. Weinstein would lead the resulting company.

Here is a link to the statement announcing the transaction.

Inquirer Columnist
0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at marmstrong@phillynews.com.

Mike Armstrong Inquirer Columnist
Also on Philly.com:
letter icon Newsletter